Skip to content

Depression research published in 2022

Page 15 of 18: studies 281 to 300 of 344, newest first. Back to the depression overview

Studies

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

Journal of Psychopharmacology February 1, 2022 Natalie Gukasyan, Alan K. Davis, Frederick S. Barrett et al. 419 citations

Background: Preliminary data suggest that psilocybin-assisted treatment produces substantial and rapid antidepressant effects in patients with major depressive disorder (MDD), but little is known about long-term outcomes. Aims: This study sought to examine the efficacy and safety of psilocybin through 12 months in participants with moderate to severe MDD who received psilocybin. Methods: This...

Mindful nonreactivity moderates the relationship between posttraumatic stress disorder and depression.

Journal of Loss and Trauma January 31, 2022 Josh Kaplan, Vanessa C Somohano, Ashley Eddy et al.

PTSD and depression represent major individual and societal burdens. Depression is commonly comorbid with PTSD among veterans, although buffers of this relationship are unclear. We evaluated whether facets of mindfulness moderated the relationship between PTSD and depression in veterans with PTSD (N = 70). Three facets - nonjudging, acting with awareness, and nonreactivity - were assessed as...

Association between Decentering and Reductions in Relapse/Recurrence in Mindfulness-Based Cognitive Therapy for Depression in Adults: A Randomized Controlled Trial

January 31, 2022 Michael Moore, Mark A. Lau, Emily A. P. Haigh et al. 2 citations

Objective: “Decentering” is defined as the ability to observe one’s thoughts and feelings as temporary, objective events in the mind (Safran & Segal, 1990), and is increasingly regarded as a candidate mechanism in mindfulness-based interventions. The current study sought to examine the role of decentering, and other related variables, in the efficacy of Mindfulness-based cognitive therapy...

DOI: 10.31231/osf.io/mx32f (opens in new tab) Mindfulness-based cognitive therapy Depression economics Relapse prevention Psychotherapist +4

ANAPANASATI MEDITATION TECHNIQUE FOR EFFECTIVE REDUCTION IN STRESS, ANXIETY & DEPRESSION: AN EXPERIMENTAL STUDY

International Journal of Advanced Research January 31, 2022 Ashish Ubhale, Swati Raje

Stress is an integral part of human life and it can increase depression and anxiety which can hamper an individuals personal life, relationship or work satisfaction. To counter the issue of stress, anxiety and depression there are various pharmacological and nonpharmacological coping methods. As an intervention, the participants were taught Anapanasati meditation (brief mindfulness meditation)...

The Role ofPsychedelics in Managing Anxiety, Depression, and Flashbacks of Individuals withPost-Traumatic Stress Disorder

International Journal of Science and Research Methodology January 31, 2022 Reace L. Hammel, Berry J. Gulliver, Shelby N. Sukich et al. 1 citation

Background: The impact of psychedelic treatment on patients with posttraumatic stress disorder (PTSD) has become more intriguing to the psychiatric field. Because of the stigma surrounding illicit drug use, the scientific communities were unable to conduct thorough studies regarding the effects of psychedelics on the brain. These drugs could help many people with mental illnesses that have not...

Effects of Mindfulness Exercise Guided by a Smartphone App on Negative Emotions and Stress in Non-Clinical Populations: A Systematic Review and Meta-Analysis.

Frontiers in Public Health January 25, 2022 Jinlong Wu, Yudan Ma, Yifan Zuo et al.

Background: Studies have acknowledged that mindfulness exercise guided by a smartphone app has a positive impact on mental health and physical health. However, mindfulness guided by a smartphone app on mental health is still in its infancy stage. Therefore, we conducted a meta-analysis evaluating the effect of mindfulness intervention guided by a smartphone app on negative emotions and stress...

Systematic Review for the Medical Applications of Meditation in Randomized Controlled Trials.

International Journal of Environmental Research and Public Health January 22, 2022 Do-Young Kim, Soo-Hwa Hong, Seung-Hyeon Jang et al.

Meditation has been increasingly adapted for healthy populations and participants with diseases. Its beneficial effects are still challenging to determine due to the heterogeneity and methodological obstacles regarding medical applications. This study aimed to integrate the features of therapeutic meditation in randomized controlled trials (RCTs). We conducted a systematic review of RCTs with...

Combined Administration of (R)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism

Pharmaceuticals January 21, 2022 Anna Rafało-Ulińska, P. Brański, Agnieszka Pałucha-Poniewiera

Ketamine is an effective, rapid-acting antidepressant drug (RAAD), but it induces side effects. To overcome these challenges, attempts have been made to use safer enantiomer ((R)-ketamine) or mGlu2/3 receptor antagonists, which induce ketamine-like effects and enhance its action. Here, we propose combining these two strategies to investigate the antidepressant-like effects of low doses of two...

Yoga and meditation, an essential tool to alleviate stress and enhance immunity to emerging infections: A perspective on the effect of COVID-19 pandemic on students.

Brain, Behavior, & Immunity - Health January 19, 2022 Nibedita Dalpati, Subhashree Jena, Shikha Jain et al.

The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has negatively impacted the global healthcare and economic systems worldwide. The COVID-19 pandemic has also created an emotional and psychological pandemic among people of all ages irrespective of economic status and physical wellbeing. As a consequence of prolonged lockdowns, one of the most...

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry

Pharmacopsychiatry January 19, 2022 Hitoshi Sakurai, Kengo Yonezawa, Hideaki Tani et al. 35 citations

Abstract Introduction There is an imminent need for faster-acting and more effective antidepressants beyond the monoaminergic hypothesis. Methods We systematically searched the US Clinical Trials registry for antidepressant compounds with completed phase II and III trials. Compounds that demonstrated significant superiority over placebo in the primary outcome measure in the latest phase of...

Mind–Body Exercises for PTSD Symptoms, Depression, and Anxiety in Patients With PTSD: A Systematic Review and Meta-Analysis

Frontiers in Psychology January 18, 2022 Lin Zhu, Long Li, Xiaozhi Li et al. 43 citations

Objectives This study aims to systematically analyze the effects of mind–body exercises on post-traumatic stress disorder (PTSD) symptoms, depression, and anxiety in patients with PTSD. Furthermore, it intends to provide scientific evidence-based exercise prescriptions. Methods Chinese (i.e., China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals, and Wanfang)...

DOI: 10.3389/fpsyg.2021.738211 (opens in new tab) Anxiety Mindfulness Meta-analysis Randomized controlled trial +7

Using meditation in a control vs. acceptance context: A preliminary evaluation of relations with anxiety, depression, and indices of well-being.

Journal of Clinical Psychology January 15, 2022 Eric D. Tifft, Shannon B. Underwood, Max Z. Roberts et al.

BACKGROUND AND OBJECTIVES Meditation practices have been marketed broadly to ameliorate human suffering. As such, individuals may seek out and use meditation to control or manage unpleasant thoughts and emotions. Emotion and thought control research suggest that meditation used in this way may potentiate unpleasant private experiences and contribute to negative outcomes. We aimed to evaluate...

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression

The International Journal of Neuropsychopharmacology January 12, 2022 Guang Chen, Li Chen, Yun Zhang et al.

Abstract Background In this post-hoc analysis, data from 2 positive, pivotal, phase 3 trials of esketamine nasal spray (ESK) in treatment-resistant depression (TRD)—short-term study (TRANSFORM-2) and maintenance study (SUSTAIN-1)—were analyzed to evaluate the relationship between dissociation and antidepressant effects of ESK. Methods Analysis by responder status, correlation analysis, and...

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression

Frontiers in Psychiatry January 12, 2022 Shannon Dames, Pamela Kryskow, Crosbie Watler 38 citations

Amid an international pandemic and a worsening mental health crisis, ketamine-assisted therapy is emerging as a promising solution for those deemed “treatment resistant.” Post-traumatic stress disorder (PTSD) and depression are on the rise, with accelerating direct (e.g., burden of suffering) and indirect (e.g., disability/role impairment and impact on family) costs. Psychedelic-assisted...

Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression

Translational Psychiatry January 10, 2022 F. Cathomas, L. Bevilacqua, Aarthi Ramakrishnan et al. 44 citations

Ketamine has rapid and sustained antidepressant effects in patients with treatment-resistant depression (TRD). However, the underlying mechanisms of action are not well understood. There is increasing evidence that TRD is associated with a pro-inflammatory state and that ketamine may inhibit inflammatory processes. We thus investigated whole blood transcriptional profiles related to TRD and...

Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder

The World Journal of Biological Psychiatry January 5, 2022 Matti Gärtner, Mischa de Rover, Lena Václavů et al. 11 citations

Ketamine is a promising treatment option for patients with Major Depressive Disorder (MDD) and has become an important research tool to investigate antidepressant mechanisms of action. However, imaging studies attempting to characterise ketamine's mechanism of action using blood oxygen level-dependent signal (BOLD) imaging have yielded inconsistent results- at least partly due to intrinsic...

Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression

Journal of Psychoactive Drugs January 3, 2022 Brianna R. Altman, Mitch Earleywine, Joseph A. de Leo 4 citations

Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear. Although perceptions of treatment credibility contribute to outcome, beliefs about the credibility of...

DOI: 10.1080/02791072.2021.2020382 (opens in new tab) Psilocybin Credibility Psychological intervention Clinical psychology +6

Chronic Δ9-tetrahydrocannabinol impact on plasticity, and differential activation requirement for CB1-dependent long-term depression in ventral tegmental area GABA neurons in adult versus young mice.

Frontiers in Neuroscience 2022 Isaac Ostlund, Michael Von Gunten, Calvin Smith et al.

The ventral tegmental area (VTA) mediates incentive salience and reward prediction error through dopamine (DA) neurons that are regulated by local VTA GABA neurons. In young mice, VTA GABA cells exhibit a form of synaptic plasticity known as long-term depression (LTD) that is dependent on cannabinoid 1 (CB1) receptors preceded by metabotropic glutamate receptor 5 (mGluR5) signaling to induce...

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report.

EXCLI journal 2022 Miriam Olivola, Vincenzo Arienti, Nicola Bassetti et al.

Major depression is a common comorbidity in autism spectrum disorder (ASD), often difficult to identify and to treat. Autistic subjects are more at risk for suicidal thoughts and behaviors compared to typically developing peers. Unfortunately, ASD individuals are more frequently treatment-resistant and often show side-effects which reduce efficacy. Intranasal esketamine has been recently...

Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson's.

Journal of geriatric psychiatry and neurology January 2022 Angeliki Bogosian, Catherine S. Hurt, John V Hindle et al.

Mindfulness-based group therapy is a rapidly growing psychological approach that can potentially help people adjust to chronic illness and manage unpleasant symptoms. Emerging evidence suggests that mindfulness-based interventions may benefit people with Parkinson's. The objective of the paper is to examine the appropriateness, feasibility, and potential cost-effectiveness of an online...